- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13:14 | Nutriband Inc. Announces $8.4M Private Placement | 142 | ACCESSWIRE | Nutriband is targeting a 505(b)(2) NDA to the FDA for marketing approval of AVERSA Fentanyl in Q1 2025 ORLANDO, FL / ACCESSWIRE / April 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company... ► Artikel lesen | |
| 01.04. | Nutriband stock climbs on receiving first order for sports brand licensee Fit for Life Group | 1 | Seeking Alpha | ||
| 01.04. | Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance | 276 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / April 1, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has been engaged... ► Artikel lesen | |
| 27.03. | Nutriband Inc.: Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA Fentanyl Transdermal Patch | 481 | ACCESSWIRE | NDA will be primarily based on a single Phase 1 human abuse potential clinical study with no Phase 2 or 3 clinical trials needed prior to submission.AVERSA Fentanyl incorporates Nutriband's Aversa abuse-deterrent... ► Artikel lesen | |
| 25.03. | Nutriband Inc.: Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting | 246 | ACCESSWIRE | Data highlights the incidence of abuse and accidental pediatric exposure of transdermal patches containing opioid and stimulant drugsNutriband's AVERSA technology addresses the unmet need for safer... ► Artikel lesen | |
| 22.03. | NVFY, BEAT and NTRB are among pre market gainers | 5 | Seeking Alpha | ||
| 04.03. | Nutriband Inc.: Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting | 363 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / March 4, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that... ► Artikel lesen | |
| 29.01. | Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st | 242 | ACCESSWIRE | Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st.ORLANDO, FL / ACCESSWIRE / January 29, 2024 / Nutriband Inc. (Nasdaq:NTRB)(Nasdaq:NTRBW) today announced... ► Artikel lesen | |
| 26.01. | Nutriband Inc.: Nutriband CEO Publishes Letter to Shareholders | 544 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / January 26, 2024 / Nutriband Inc. ("Company") (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights... ► Artikel lesen | |
| 25.01. | NutriBand Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.01. | NutriBand Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.01. | Nutriband partners with Kindeva for fentanyl patch development | 1 | Investing.com | ||
| 05.01. | Nutriband Inc.: Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa Fentanyl, an Abuse Deterrent Fentanyl Patch | 473 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / January 5, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today announced it has signed a... ► Artikel lesen | |
| 29.12.23 | NutriBand Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 13.12.23 | NutriBand Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 28.11.23 | Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling | 531 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / November 28, 2023 / Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of its new Heating and Cooling... ► Artikel lesen | |
| 08.11.23 | Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape | 445 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / November 8, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that it has signed a supplier agreement with market leading kinesiology tape company, KT Tape.... ► Artikel lesen | |
| 11.10.23 | Nutriband Inc.: Nutriband's Aversa Buprenoprhine May Reach Peak Annual Sales of $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm | 491 | ACCESSWIRE | ORLANDO, FL / ACCESSWIRE / October 11, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, today announced it has completed... ► Artikel lesen | |
| 20.09.23 | Nutriband's Innovative Patent Breaks New Ground in Transdermal Medications | 331 | JCN Newswire | Revolutionary AVERSA Technology Sets New Standard for Opioid Patch SafetyOrlando, FL, Sept 20, 2023 - (ACN Newswire) - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal... ► Artikel lesen | |
| 20.09.23 | Nutriband Inc.: Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology | 533 | ACCESSWIRE | Patent issuance expands U.S. patent portfolio for AVERSA transdermal abuse deterrent technologyORLANDO, FL / ACCESSWIRE / September 20, 2023 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer... ► Artikel lesen |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 26,325 | +0,32 % | KI im Gesundheitswesen mit evotec, Defence Therapeutics, Bayer: Revolutionäre Fortschritte und medizinische Durchbrüche | Im Gesundheitswesen nimmt Künstliche Intelligenz (KI) immer mehr an Fahrt auf. KI-basierte Systeme können medizinische Datenbanken nutzen, um in der Forschung kostbare Zeit zu sparen, die es Unternehmen... ► Artikel lesen | |
| PFIZER | 24,355 | +2,12 % | JPMORGAN stuft PFIZER INC auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer vor Zahlen fürs erste Quartal auf "Neutral" mit einem Kursziel von 30 US-Dollar belassen. Der Pharmakonzern dürften die... ► Artikel lesen | |
| GILEAD SCIENCES | 62,41 | +0,40 % | Virushepatitis bis 2030 eliminieren: Gilead Sciences fördert zahlreiche Projekte weltweit mit 4 Millionen US-Dollar - auch in Deutschland | Martinsried bei München (ots) - - Gilead vergibt 4 Millionen US-Dollar weltweit (ohne die Vereinigten Staaten) durch das Förderprogramm "ALL4LIVER Grant" -- Die World Hepatitis Alliance und hochrangige... ► Artikel lesen | |
| GSK | 18,590 | +0,90 % | GSK Says ZOSTER-049 Study Showed Its Shingles Vaccine Maintains Long-term Efficacy | LONDON (dpa-AFX) - GSK plc (GSK.L) Wednesday announced positive data from the ZOSTER-049 long-term follow-up phase III trial of its shingles vaccine, Shingrix.Final data from ZOSTER-049 study... ► Artikel lesen | |
| MERCK & CO | 118,20 | +0,51 % | Health Canada Approves Merck's Keytruda Plus Chemotherapy To Treat Gastric Cancers | KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) on Friday said its Keytruda in combination with fluoropyrimidine- and platinum-containing-chemotherapy has been approved by Health Canada for... ► Artikel lesen | |
| TILRAY BRANDS | 1,612 | -0,56 % | Cannabis-Aktien: Cannabis-Rally zerfällt zu Staub. Tilray und Canopy im Fokus. | Anzeige / WerbungDer Erwartungen waren hoch. Die Enttäuschung ist nun mindestens genauso groß.Der Erwartungen waren hoch. Die Enttäuschung ist nun mindestens genauso groß. Der Start in die Berichtssaison... ► Artikel lesen | |
| INNOCAN PHARMA | 0,177 | -4,06 % | X-Leak: Jetzt der Mega-Meilenstein - Kurseskalation vorprogrammiert? | ||
| TAAT GLOBAL ALTERNATIVES | 0,210 | +19,66 % | TAAT Global Alternatives Inc (2): TAAT to issue update on FY 2023 results filing April 26 | ||
| BEVCANNA ENTERPRISES | 1,245 | -6,04 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.02.2024 | The following instruments on XETRA do have their first trading 23.02.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.02.2024
Aktien
1 CA28655A1066 Eli Lilly and Company... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,012 | -27,27 % | Mydecine Innovations Group Inc - Closing of Share for Debt Settlement | Mydecine Innovations Group Inc - Closing of Share for Debt Settlement
PR Newswire
LONDON, United Kingdom, April 16
MYDECINE INNOVATIONS GROUP INC.ANNOUNCES CLOSING OF... ► Artikel lesen | |
| ASTRIA THERAPEUTICS | 10,400 | +5,05 % | Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update | BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,012 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake to file FY results May 31; MCTO granted | ||
| TRYP THERAPEUTICS | 0,031 | 0,00 % | Tryp Therapeutics Announces 99.92% Votes Cast by Shareholders in Favor of Arrangement Agreement at Annual General and Special Meeting of Securityholders, and Receipt of Final Order | KELOWNA, BC / ACCESSWIRE / March 12, 2024 / Tryp Therapeutics, Inc. ("Tryp" or the "Company") (CSE:TRYP)(OTCQB:TRYPF) is pleased to announce that the Company's securityholders overwhelmingly approved... ► Artikel lesen | |
| PSYCHED WELLNESS | 0,021 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness and Gotham Green Partners to Close Final Tranche of US$2.5M for a Total of US$7.5M Raised and Partner with Strategic Advisors to Build Consumer Packaged Goods Derived from AME-1 | Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production... ► Artikel lesen | |
| COMPASS PATHWAYS | 7,850 | -0,63 % | Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors | David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a biotechnology... ► Artikel lesen |
NUTRIBAND INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 3,760 Euro und damit -4,08 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
